Project Details
Description
Phase III, Multicenter, Randomized, Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Tocilizumab in Subjects with Giant Cell Arteritis
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/14 → 9/30/16 |
Funding
- HOFFMANN-LA ROCHE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.